Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | MLH1 low |
| Gene Variant Detail | |
| Relevant Treatment Approaches |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07729046 | Phase II | Neratinib + Tamoxifen Exemestane Exemestane + Neratinib Tamoxifen Anastrozole + Neratinib Letrozole + Neratinib Letrozole Anastrozole Fulvestrant + Neratinib Fulvestrant | Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer | Not yet recruiting | USA | 0 |